Persistent airflow obstruction in patients with asthma: Characteristics of a distinct clinical phenotype

Elissavet Konstantellou， Andriana I. Papaioannou， Stelios Loukidese， George Patentalakis， Anastasia Papaporfyriou， Georgios Hillas， Spyros Papiris， Nikolaos Koulouris， Petros Bakakos， Konstantinos Kostikas

Background

Some patients with asthma present persistent airflow limitation but their clinical and inflammatory characteristics have not been extensively described. In this study we aimed to identify differences in the clinical, functional and inflammatory characteristics between patients with asthma with and without persistent airflow obstruction.

Methods

Patients (n = 170) were consecutively recruited from two tertiary Asthma Clinics. Patients' demographics, pulmonary function tests, inflammatory cells in induced sputum, bronchial hyperresponsiveness (BHR, PD15 to methacholine) and treatment regimens were recorded.

Results

Sixty patients (35.3%) presented persistent airflow obstruction. Besides differences in lung function, patients with persistent obstruction presented, lower methacholine PD20, higher exhaled NO, and higher eosinophil and neutrophil counts in induced sputum. The majority (71.7%) of the patients with persistent obstruction fulfilled the ATS criteria for severe refractory asthma (SRA), in contrast to 4.5% in the group without persistent obstruction. A cluster analysis identified three clinically relevant clusters: Cluster 1 (n = 56, not related to persistent airflow obstruction) included non-atopic patients, who did not receive high-dose ICS without SRA; Cluster 2 (n = 53, related to persistent airflow obstruction) included atopic patients, receiving high-dose ICS and/or oral CS, fulfilling SRA criteria; Cluster 3 (n = 61, not related to persistent airflow obstruction) included atopic patients not receiving high-dose ICS, without SRA.

Conclusions

Asthma patients with persistent airflow obstruction present a distinct asthma phenotype, with significant differences in clinical, functional and inflammatory characteristics compared to patients without fixed airway obstruction. These patients present more often severe refractory asthma and require more intense treatment.

respiratory medicine

November 2015Volume 109, Issue 11, Pages 1404–1409

DOI: http://dx.doi.org/10.1016/j.rmed.2015.09.009 |